1 of 1
Story summary
- U.S. President Donald Trump nominated White House aide Heidi Overton to become FDA commissioner.
- The nomination follows unprecedented cyclospora outbreaks that sickened many Americans this summer.
- Former and current FDA officials warned Overton may prioritize presidential loyalty over agency rebuilding.
- UC Berkeley professor John Swartzberg said low morale will make agency improvement difficult.
- Overton’s appointment requires Senate confirmation, but no hearing date has been set.
